Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price objective cut by Canaccord Genuity Group from $10.00 to $6.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently weighed in on AKYA. BTIG Research dropped their price target […]